Sort
30,917 grants matching “tumor microenvironment”
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
$474,416Wafik S El-Deiry · Brown University · R01 · FY2022 · CA
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
$474,416Wafik S El-Deiry · Brown University · R01 · FY2023 · CA
The Role of Lumican in the cornea
$474,342Shukti Chakravarti · Johns Hopkins University · R56 · FY2007 · EY
Targeting lymph node metastases to block cancer progression
$474,295Timothy P Padera · Massachusetts General Hospital · R01 · FY2024 · CA
Modulation of Tumor Microenvironment by Microbiome in Head and Neck Cancer
$474,275Shi-Long Lu · University Of Colorado Denver · R56 · FY2019 · DE
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$474,214David R Rowley · Baylor College Of Medicine · R01 · FY2019 · CA
CD19 Directed CAR Therapy
$474,213Carl H. June · University Of Pennsylvania · R01 · FY2013 · CA
Leader cell development and function in Breast Tumor Collective Migration
$474,135Gregory Longmore · Washington University · R01 · FY2024 · CA
Neoadjuvant immunotherapy approaches to early stage melanoma
$474,126Meenhard Herlyn · Wistar Institute · P50 · FY2025 · CA
Intrapleural immunotherapeutic nanoparticles for MPE treatment
$473,950Dawen Zhao · Wake Forest University Health Sciences · R01 · FY2021 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$473,941Paul Mathew · Tufts Medical Center · R01 · FY2021 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$473,941Paul Mathew · Tufts Medical Center · R01 · FY2020 · CA
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
$473,937Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma
$473,881Josep M Llovet · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Computational Methods for Identifying Non-coding Cancer Drivers
$473,876Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Metabolic and molecular regulation of myeloid cell functions in brain cancer
$473,753Filippo Veglia · Wistar Institute · R01 · FY2025 · NS
Targeting UHRF1 in combinational immunotherapy
$473,749Xiao-Fan Wang · Duke University · R01 · FY2019 · CA
PD-1/PD-L1 modulation in cancer therapy
$473,681Drew M. Pardoll · Johns Hopkins University · R01 · FY2019 · CA
Reversing cancer immunosuppression using attenuated Listeria monocytogenes
$473,641Daniel A Portnoy · University Of California Berkeley · R01 · FY2024 · CA
Reversing cancer immunosuppression using attenuated Listeria monocytogenes
$473,641Daniel A Portnoy · University Of California Berkeley · R01 · FY2025 · CA
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
$473,623Ankur Singh · Georgia Institute Of Technology · R01 · FY2021 · CA
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
$473,620Raymond B Birge · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Project 2: Investigating cell intrinsic and extrinsic drivers of prostate cancer bone metastasis
$473,522Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2023 · CA
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
$473,506Raymond B Birge · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA
Non-oncogene addiction in cancer cells
$473,481Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA